LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

LLY

898.5

-1.78%↓

JNJ

239.25

-0.3%↓

ABBV

211.26

+2.28%↑

NVS

149.54

-0.8%↓

MRK

118.94

-0.3%↓

Search

Smith & Nephew PLC ADR

Закрыт

32.23 -0.31

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

32.08

Макс.

32.59

Ключевые показатели

By Trading Economics

Доход

35M

331M

Продажи

203M

3.2B

P/E

Средняя по отрасли

22.336

57.05

Дивидендная доходность

2.45

Рентабельность продаж

10.368

Сотрудники

16,988

EBITDA

133M

856M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

+7.73% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.45%

2.52%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-1.6B

14B

Предыдущая цена открытия

32.54

Предыдущая цена закрытия

32.23

Техническая оценка

By Trading Central

Уверенность

Bullish Evidence

Smith & Nephew PLC ADR График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

25 мар. 2026 г., 20:20 UTC

Приобретения, слияния, поглощения

Infosys Agrees to Acquire Stratus

25 мар. 2026 г., 23:58 UTC

Отчет

Guming Proposes 2025 Final Dividend of HK$0.50 >1364.HK

25 мар. 2026 г., 23:58 UTC

Отчет

Guming: Seek to Further Expand Coffee Product Line, Explore New Food Categories >1364.HK

25 мар. 2026 г., 23:57 UTC

Отчет

Guming: Aim to Expand Store Network in China, Evaluate Overseas Opportunities >1364.HK

25 мар. 2026 г., 23:57 UTC

Отчет

Guming Store Network Rose 37% on Year to 13,554 Stores as of Dec. 31, 2025 >1364.HK

25 мар. 2026 г., 23:56 UTC

Отчет

Guming 2025 Rev CNY12.91B Vs. CNY8.79B >1364.HK

25 мар. 2026 г., 23:56 UTC

Отчет

Guming 2025 Net CNY3.11B Vs. Net CNY1.48B >1364.HK

25 мар. 2026 г., 23:41 UTC

Обсуждения рынка

Nikkei May Trade Rangebound Amid Uncertainty Over U.S.-Iran Talks -- Market Talk

25 мар. 2026 г., 23:41 UTC

Отчет

These Stocks Are Today's Movers: Arm, Intel, AMD, Firefly Aerospace, Robinhood, JD.com, Sarepta, and More -- Barrons.com

25 мар. 2026 г., 23:34 UTC

Обсуждения рынка
Главные новостные события

Gold Declines on Possible Technical Correction -- Market Talk

25 мар. 2026 г., 22:08 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

25 мар. 2026 г., 22:08 UTC

Обсуждения рынка

Synlait Milk's Outlook Depends on Dunsandel -- Market Talk

25 мар. 2026 г., 22:07 UTC

Отчет

China Mengniu Dairy: Weak Consumer Demand Weighed on Rev >2319.HK

25 мар. 2026 г., 22:07 UTC

Отчет

China Mengniu Dairy Plans Steady Increase in Dividends For Next Three Years >2319.HK

25 мар. 2026 г., 22:07 UTC

Отчет

China Mengniu Dairy: 2025 Net Supported by Absence of Impairment Provisions Made Last Year >2319.HK

25 мар. 2026 г., 22:07 UTC

Отчет

China Mengniu Dairy 2025 Rev CNY82.24B Vs. CNY88.67B >2319.HK

25 мар. 2026 г., 22:07 UTC

Отчет

China Mengniu Dairy 2025 Net CNY1.55B Vs. Net CNY104.51M >2319.HK

25 мар. 2026 г., 21:58 UTC

Обсуждения рынка

Amplitude Energy Oversold on Isabella-1 Well Disappointment -- Market Talk

25 мар. 2026 г., 21:37 UTC

Обсуждения рынка

Miran: AI and Deregulation Are Positive Supply Shocks To Economy -- Market Talk

25 мар. 2026 г., 21:14 UTC

Приобретения, слияния, поглощения

St Barbara: Expects to Record Gain on Sale of Roughly A$500 Million Upon Completion

25 мар. 2026 г., 21:13 UTC

Приобретения, слияния, поглощения

St Barbara: All Conditions Satisfied, Waived on Lingbao Deal

25 мар. 2026 г., 21:12 UTC

Приобретения, слияния, поглощения

Closing M&A Deals Bring Opportunity. Janus Henderson and Other Stocks to Buy. -- Barrons.com

25 мар. 2026 г., 20:50 UTC

Обсуждения рынка

Financial Services Roundup: Market Talk

25 мар. 2026 г., 20:50 UTC

Обсуждения рынка
Приобретения, слияния, поглощения

Health Care Roundup: Market Talk

25 мар. 2026 г., 20:33 UTC

Приобретения, слияния, поглощения

KKR & Co.: Entered Agreement to Sell CoolIT Systems to Ecolab in Transaction Valued at $4.75B >KKR >KKR

25 мар. 2026 г., 20:31 UTC

Отчет

The SpaceX IPO Is Coming. Cathie Wood's Ark Venture and More Funds to Get in on the Action. -- Barrons.com

25 мар. 2026 г., 20:15 UTC

Приобретения, слияния, поглощения

KKR Scores One of Its Best Bets With Sale of Data-Center Cooling Business -- WSJ

25 мар. 2026 г., 20:15 UTC

Приобретения, слияния, поглощения

CoolIT Employees Set to Receive Average Payouts of $240,000, Executives Say -- WSJ

25 мар. 2026 г., 20:15 UTC

Приобретения, слияния, поглощения

CoolIT Deal Ranks Among KKR's Top-4 Highest Earning Investments in Past 20 Years, Executives Say -- WSJ

25 мар. 2026 г., 20:15 UTC

Приобретения, слияния, поглощения

KKR Set to Make 15x Investment From $4.75B Sale of CoolIT to Ecolab, Executives Say -- WSJ

Сравнение c конкурентами

Изменение цены

Smith & Nephew PLC ADR Прогноз

Целевая цена

By TipRanks

7.73% рост

Прогноз на 12 месяцев

Средняя 34.96 USD  7.73%

Максимум 35 USD

Минимум 34.91 USD

Основано на мнении 2 аналитиков Wall Street, спрогнозировавших целевые цены для Smith & Nephew PLC ADR на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

2 ratings

0

Покупка

2

Удержание

0

Продажа

Техническая оценка

By Trading Central

26.64 / 28.37Поддержка и Сопротивление

Краткосрочная

Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

Bullish Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Smith & Nephew PLC ADR

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
help-icon Live chat